FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Heart-Valve, Non-Allograft Tissue
PMA: P170006
·
Supplement: S020
·
Decision Mar 1, 2022
Classifications
1
FEI Numbers
19
Registration Numbers
19
Basic Information
- Device Name
- Heart-Valve, Non-Allograft Tissue
- Trade Name
- Avalus Bioprosthesis
- PMA Number
- P170006
- Supplement Number
- S020
- Device Class
- FDA Class 3
- Product Code
- LWR
- Generic Name
- heart-valve, non-allograft tissue
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- March 1, 2022
- Date Received
- February 28, 2022
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Use of a new data management system for microbiology laboratory test data and data reporting at the Medtronic Tijuana facility for the Evolut R, Evolut PRO, Evolut PRO+, and Evolut FX Transcatheter Aortic Valves (TAVs), Harmony and Melody Transcatheter Pulmonic Valves (TPV), and Avalus bioprosthesis products.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LWR | Heart-Valve, Non-Allograft Tissue | FDA class 3 | Unknown |